As shown in Fig. 3C, regardless of the tumor-dominant group or the TME-dominant group, the abundance of CD163+ M2 macrophages was significantly enriched in the high ImmuneScore subgroup compared to the low ImmuneScore subgroup (P < 0.001). Here, CD163 is linked to neoplasm.